Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

FdUMP[10] is active against acute myeloid leukemia in vitro and in vivo

Jan. 5, 2011

Mechanism of action of darinaparsin in Hodgkin's and T-cell lymphomas clarified

Jan. 5, 2011

POL-6326 is well tolerated and effectively mobilizes hematopoietic stem cells in phase II trial

Jan. 4, 2011

KPT-127 is toxic to hematological cancer cells

Jan. 4, 2011

Several inhibitors of botulinum neurotoxins presented at Pacifichem 2010

Jan. 4, 2011

MK-2461 is active in model of multiple myeloma

Jan. 3, 2011

IMMU-114 shows potential for treating GVHD

Jan. 3, 2011

Phase II data presented on AIC-246 for human cytomegalovirus infection

Jan. 3, 2011

Anti-HIV-1 activity of aciclovir and potentiation by ribavirin

Jan. 3, 2011

Selective SYK inhibitors P505-15 and P459-72 show anticancer potential

Jan. 3, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...